Veterinary Hematology Analyzers Market By Product Type (Tabletop Analyzers, Portable Analyzers); By Technology (3-Part Differential Analyzers, 5-Part Differential Analyzers); By Animal Type (Companion Animals, Livestock); By End User (Veterinary Clinics, Diagnostic Laboratories); By Geography (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2026–2032

How Are Automated Blood Testing and In-Clinic Diagnostics Shaping the Veterinary Hematology Analyzers Market? – (Updated On: 13th-Oct-2026)

The Global Veterinary Hematology Analyzers Market was valued at USD 383.40 million in 2025 and is projected to reach USD 703.63 million by 2032, expanding at an estimated CAGR of 9.06% during 2026–2032, according to Strategic Market Research. Veterinary hematology analyzers are automated diagnostic instruments used to examine animal blood samples and perform complete blood counts (CBCs).

 

Veterinary hematology analyzers are widely used for routine health examinations, pre-surgical assessments, emergency diagnosis, and treatment monitoring. A U.S. study involving dogs with chronic kidney disease reported that approximately 75% of 253 dogs with available diagnostic-testing information underwent complete blood count testing, highlighting the role of hematology analysis in evaluating animals with chronic conditions. Blood cell monitoring is also important for animals undergoing chemotherapy, receiving treatment for severe infections, or experiencing anemia and bleeding disorders.

 

Adoption is also evident in manufacturer instrument placements. IDEXX Laboratories reported an installed base of approximately 51,800 premium veterinary hematology instruments worldwide in 2024, following around 8,200 instrument placements during the year. Its ProCyte One and ProCyte Dx systems support automated in-clinic blood analysis, with technologies designed to differentiate blood-cell populations and deliver comprehensive CBC results. IDEXX also reported delivering more than 20,000 ProCyte One analyzers globally since its 2021 commercial launch, highlighting demand for compact point-of-care hematology systems.

 

Overall, the market's expansion is closely linked to rising in-clinic CBC testing, wider adoption of advanced 5-part differential analyzers, and recurring demand for reagents and consumables. Veterinary clinics and diagnostic laboratories investing in automated testing are expected to remain important revenue contributors through 2032.

 

Which Segments Are Leading the Veterinary Hematology Analyzers Market, and Which Are Growing the Fastest?

By Product Type: Tabletop Analyzers Lead Revenue While Portable Systems Expand Field-Based Testing

Leading Subsegment – Tabletop Analyzers

Tabletop analyzers, also known as benchtop models, dominated the Veterinary Hematology Analyzers Market with an estimated 74% market share, valued at USD 283.72 million in 2025, and are projected to grow at a CAGR of 8.60% during 2026–2032. Their strong market position reflects widespread adoption across veterinary clinics, multi-specialty animal hospitals, and reference laboratories, where multi-species blood testing supports routine health assessments, disease diagnosis, pre-surgical evaluations, and treatment monitoring. High testing volumes and the need for consistent laboratory results continue to strengthen their clinical importance.

Fastest-Growing Subsegment – Portable Analyzers

Portable and handheld veterinary hematology analyzers enable rapid Complete Blood Count (CBC) testing and basic hemogram assessments at veterinary clinics, mobile practices, and field locations without relying on centralized laboratories. Portable analyzers accounted for an estimated 26% of the global Veterinary Hematology Analyzers Market, representing USD 99.68 million in 2025, and are projected to register the fastest CAGR of 10.31% during 2026–2032. Their adoption is supported by decentralized veterinary care, faster diagnostic decisions, and increasing access to blood testing in remote animal healthcare settings.

 

By Technology: 5-Part Differential Analyzers Lead Both Market Revenue and Growth

Leading and Fastest-Growing Subsegment – 5-Part Differential Analyzers

Five-part differential hematology analyzers dominated the Veterinary Hematology Analyzers Market, accounting for an estimated 57% market share, valued at USD 218.54 million in 2025, and are projected to record the fastest CAGR of 10.78% during 2026–2032. Five-part analyzers separately identify and quantify five white blood cell subtypes: neutrophils, lymphocytes, monocytes, eosinophils, and basophils. Their ability to provide detailed leukocyte profiles supports the diagnosis and monitoring of infections, inflammatory conditions, and immune disorders in companion animals, strengthening their adoption across veterinary hospitals and diagnostic laboratories.

Established Subsegment – 3-Part Differential Analyzers

Three-part differential analyzers accounted for an estimated 43% share of the global Veterinary Hematology Analyzers Market, valued at USD 164.86 million in 2025, and are projected to expand at a CAGR of 6.50% during 2026–2032. Using electrical impedance technology, 3-part analyzers measure and classify white blood cells into three groups: lymphocytes, mid-cells (monocytes, eosinophils, and basophils), and granulocytes (primarily neutrophils). Their affordability, simplified operation, and suitability for routine blood screening support widespread adoption across veterinary clinics, particularly small and medium-sized practices.

 

By Animal Type: Companion Animals Dominate Revenue and Record the Fastest Growth

Leading and Fastest-Growing Subsegment – Companion Animals

Companion animals, primarily dogs and cats, represent the largest category in the Veterinary Hematology Analyzers Market, accounting for an estimated 79% market share and USD 302.89 million in 2025, with the fastest projected CAGR of 9.50% during 2026–2032. Increasing veterinary blood testing for routine health examinations, disease diagnosis, and treatment monitoring is influencing analyzer design, species-specific software programming, and diagnostic capabilities. Growing adoption of in-clinic hematology testing across veterinary hospitals and companion animal clinics is further supporting analyzer installations and technology upgrades worldwide.

Other Subsegment – Livestock

Livestock, including cattle, sheep, goats, and pigs, accounted for an estimated 21% share of the global Veterinary Hematology Analyzers Market, valued at USD 80.51 million in 2025, with a projected CAGR of 7.31% during 2026–2032. Veterinary hematology analyzers are widely used in livestock health management to assess blood cell counts, detect infections, identify anemia, and monitor herd health. Increasing veterinary diagnostic testing across dairy farms, commercial breeding facilities, and livestock production operations is supporting wider adoption of automated hematology analyzers for routine screening and disease management.

 

By End User: Veterinary Clinics Lead In-House Blood Testing Adoption

Leading and Fastest-Growing Subsegment – Veterinary Clinics

Veterinary clinics accounted for an estimated 71% market share, valued at USD 272.21 million in 2025, and are projected to register the fastest CAGR of 9.40% during 2026–2032. Veterinary clinics play a central role in routine blood testing, disease diagnosis, pre-surgical screening, and treatment monitoring for companion animals. Increasing patient visits, preventive health examinations, and the need for rapid blood cell analysis encourage clinics to adopt automated hematology analyzers, improving diagnostic efficiency, supporting timely clinical decisions, and expanding in-house laboratory testing capabilities.

Other Subsegment – Diagnostic Laboratories

Diagnostic laboratories accounted for an estimated 29% share of the Veterinary Hematology Analyzers Market, valued at USD 111.19 million in 2025, and are projected to grow at a CAGR of 8.20% during 2026–2032. Veterinary diagnostic laboratories complement in-clinic hematology testing through advanced species-specific calibration, standardized quality control, expert blood cell morphology assessment, and comprehensive evaluation of complex animal health conditions. Increasing laboratory referrals for specialized hematological investigations and critical veterinary cases are supporting greater adoption of automated hematology analyzers across veterinary reference laboratories and specialized diagnostic facilities worldwide.

 

By Geography: North America Leads Global Revenue While Asia-Pacific Offers the Fastest Expansion

Leading Region – North America

North America leads the Global Veterinary Hematology Analyzers Market, accounting for the largest estimated 39% market share, valued at USD 149.53 million in 2025, with a projected CAGR of 8.30% during 2026–2032. The region’s strong position reflects widespread adoption of automated blood testing across veterinary hospitals, diagnostic laboratories, and specialty animal clinics. Increasing companion animal healthcare expenditure, routine blood screening, and growing use of advanced hematology analyzers for detecting anemia, infections, and blood disorders continue to strengthen the region’s veterinary diagnostic capabilities.

Fastest-Growing Region – Asia-Pacific

Asia-Pacific accounted for an estimated 26% of the global veterinary hematology analyzers market, valued at USD 99.68 million in 2025, and is projected to register the fastest regional CAGR of 11.26% during 2026–2032. Veterinary diagnostic facilities across China, India, Japan, and South Korea are increasingly transitioning from manual microscopic blood cell counting to automated hematology testing. Expanding veterinary clinic networks, rising companion animal healthcare expenditure, and greater emphasis on livestock disease monitoring are accelerating the adoption of automated blood analyzers across the region.

 

Who Are the Leading Companies in the Veterinary Hematology Analyzers Market?

IDEXX Laboratories: Expanding In-Clinic Hematology Testing Through Advanced Diagnostic Platforms

IDEXX Laboratories is one of the leading global manufacturers of veterinary hematology analyzers, supported by its extensive installed instrument base, advanced diagnostic technologies, and recurring consumables business. Its ProCyte One and ProCyte Dx hematology analyzers provide automated complete blood counts and detailed blood-cell differentiation for companion animals. ProCyte One incorporates advanced imaging and artificial intelligence capabilities to support in-clinic blood analysis, while integration with the IDEXX VetLab ecosystem enables veterinarians to consolidate diagnostic results and monitor animal health.

According to IDEXX's 2025 annual report, the company had approximately 56,000 premium hematology instruments installed worldwide at the end of 2025, compared with 52,000 in 2024, representing approximately 7.7% annual growth. Its broader IDEXX VetLab consumables revenue reached USD 1.497 billion in 2025, increasing 14.8% year over year, while Companion Animal Group diagnostic instrument revenue increased 51.8% to USD 200.2 million. These figures cover broader diagnostic product categories rather than veterinary hematology alone. The expanding instrument network and recurring consumables sales strengthen IDEXX's commercial position through continued diagnostic utilization, customer retention, and integrated testing solutions.

Other Key Companies and Their Market Roles:

• Zoetis (Abaxis): Supplies the Vetscan HM5 hematology analyzer, offering 3-part and 5-part differential testing across 15 animal species, with results in approximately 3–4 minutes.

• Boule Diagnostics (Exigo): Manufactures the Exigo H400 veterinary hematology analyzer, supporting 12 animal profiles and up to 53 samples per hour, targeting routine blood testing in veterinary clinics.

• Diatron: Offers the Abacus Vet5 analyzer for automated 5-part differential blood testing, serving veterinary practices through compact equipment and dedicated reagent solutions.

• Mindray Animal Medical: Provides the BC-5000 Vet analyzer using laser scattering and flow cytometry, supporting 13 predefined animal types and throughput of up to 60 samples per hour.

• HORIBA: Introduced the Yumivet VH2500 in May 2026, offering 57 hematology parameters, a 9-part differential, and approximately 30-second analysis times, targeting advanced veterinary laboratories.

 

Analyst Commentary: How Will Automated CBC Testing and Recurring Reagents Shape In-Clinic Veterinary Diagnostics?

The veterinary hematology analyzers market is shifting toward faster, more precise in-clinic blood testing, with 5-part differential technology becoming increasingly important for comprehensive animal diagnostics. The strongest commercial opportunities lie in automated CBC testing for companion animals, point-of-care diagnostic adoption, and recurring reagent consumption. Increasing emphasis on early disease detection, routine health screening, and treatment monitoring is accelerating the transition from outsourced laboratory testing to in-house diagnostics, making testing accuracy, turnaround time, and cost efficiency critical factors shaping market adoption.

 

Veterinary Hematology Analyzers Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 383.40 Million
Revenue Forecast in 2032	USD 703.63 Million
Overall Growth Rate	CAGR of 9.06% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Product Type, By Technology, By Animal Type, By End User, By Geography
By Product Type	Tabletop Analyzers, Portable Analyzers
By Technology	3-Part Differential Analyzers, 5-Part Differential Analyzers
By Animal Type	Companion Animals, Livestock
By End User	Veterinary Clinics, Diagnostic Laboratories
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East & Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, Spain, China, Japan, South Korea, India, Australia, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	Increasing in-clinic CBC testing, growing adoption of automated veterinary diagnostics, rising demand for 5-part differential hematology analyzers, increasing companion animal healthcare expenditure, growing need for rapid disease diagnosis and treatment monitoring, expansion of veterinary clinic networks, rising adoption of portable and point-of-care analyzers, and recurring demand for analyzer reagents and consumables
Customization Option	Available upon request